title: Dual role of glutathione in selenite-induced oxidative stress and apoptosis in human hepatoma cells.
abstract: It is well known that glutathione, the major intracellular antioxidant, is closely involved in the metabolism and bioactivity of selenium. In the present study, glutathione was demonstrated to play a dual role on selenite (Se)-induced oxidative stress and apoptosis in human hepatoma HepG(2) cells. The experiment was carried out in two different modes to modulate intracellular reduced glutathione (GSH) content. In Mode A (pretreatment), cells were pretreated with N-acetylcysteine (NAC), buthionine sulfoximine (BSO), or GSH prior to Se exposure. In Mode B (simultaneous treatment), cells were treated with Se and NAC, BSO, or GSH simultaneously. It was found that Se-induced oxidative stress and apoptosis are closely related to the intracellular level of GSH. Both the increase and depletion of GSH content significantly enhanced Se-induced oxidative stress and apoptosis in HepG(2) cells. Results from this study clearly demonstrated that GSH has a dual role in the effects of Se on cancer cells: (i) GSH acts as a pro-oxidant, facilitating Se-induced oxidative stress, and (ii) GSH acts as an antioxidant, protecting against Se-induced oxidative stress and apoptosis. Understanding such a unique association between GSH and Se may help to explain the controversy in the literature over the complex relationship between selenium and glutathione, and ultimately the capability of selenium to prevent cancer.
authors.affiliation: Department of Community, Occupational and Family Medicine, Faculty of Medicine (MD3), National University of Singapore, Singapore. cofshm@nus.edu.sg
authors.forename: H
authors.initials: H
authors.lastname: Shen
authors.forename: C
authors.initials: C
authors.lastname: Yang
authors.forename: J
authors.initials: J
authors.lastname: Liu
authors.forename: C
authors.initials: C
authors.lastname: Ong
mesh_terms: D000111:Acetylcysteine / Q000633:toxicity; D017209:Apoptosis / Q000187:drug effects*; D019328:Buthionine Sulfoximine / Q000633:toxicity; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000473:pathology*; D005978:Glutathione / Q000502:physiology* / Q000633:toxicity; D006131:Growth Inhibitors / Q000633:toxicity; D006801:Humans; D007424:Intracellular Fluid / Q000187:drug effects / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology*; D018384:Oxidative Stress / Q000187:drug effects*; D017382:Reactive Oxygen Species / Q000378:metabolism; D018038:Sodium Selenite / Q000633:toxicity*; D014407:Tumor Cells, Cultured
chemical_list: D006131:Growth Inhibitors; D017382:Reactive Oxygen Species; D019328:Buthionine Sulfoximine; D007770:L-Lactate Dehydrogenase; D005978:Glutathione; D018038:Sodium Selenite; D000111:Acetylcysteine